Skip to content

Abnormal Circulating Antimullerian Hormone Concentration C4476970

Published: July 22, 2026Updated: August 25, 2026

A hormone level that reflects ovarian function and egg supply. Testing helps assess reproductive health, though results need professional interpretation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe Pelvic Pain

Intense or sudden pelvic discomfort that may indicate ovarian cyst rupture or torsion.

Seek immediate medical attention for sudden, severe pelvic pain or pain accompanied by fever, vomiting, or fainting.

Menstrual Irregularities

(reproductive)

Changes in menstrual cycle timing, flow amount, or duration; periods may become infrequent, absent, or unpredictable.

Frequency: 70-80% of patients

Infertility

(reproductive)

Difficulty conceiving or reduced ability to become pregnant due to ovarian function changes.

Frequency: 60-75% of patients

Fatigue

(constitutional)

Persistent tiredness and lack of energy that interferes with daily activities.

Frequency: 40-50% of patients

Excessive Hair Growth

(dermatologic)

Increased hair growth on face, chest, back, or abdomen due to hormone imbalance.

Frequency: 30-40% of patients

Acne and Skin Changes

(dermatologic)

Persistent or severe acne, oily skin, or other dermatological changes linked to hormonal fluctuations.

Frequency: 25-35% of patients

Weight Changes

(constitutional)

Unexplained weight gain or difficulty losing weight, particularly around the midsection.

Frequency: 30-40% of patients

Hot Flashes

(endocrine)

Sudden feelings of heat, sweating, and flushing, often affecting the face and upper body.

Frequency: 35-45% of patients

Night Sweats

(endocrine)

Excessive sweating during sleep that may soak through clothing or bedding.

Frequency: 25-35% of patients

Mood Changes

(psychiatric)

Emotional fluctuations including irritability, anxiety, depression, or emotional sensitivity.

Frequency: 30-40% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive fertility assessment

Detailed evaluation including ovarian reserve testing, ultrasound assessment, and consultation with fertility specialists to interpret AMH findings in context of reproductive goals.

monitoring
2

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Reproductive health optimization

Lifestyle modifications including smoking cessation, alcohol reduction, maintaining healthy BMI, and reducing stress to support overall reproductive function alongside AMH findings.

lifestyle

Additional treatment options

Assisted reproductive technology planning

Advanced fertility treatments including IVF or egg freezing may be discussed based on AMH results and individual circumstances for family planning purposes.

procedure

Antioxidant-rich nutritional support

Dietary approach emphasizing antioxidants, vitamins, and minerals that support ovarian health and overall reproductive function.

dietary

Acupuncture and integrative approaches

Complementary therapies such as acupuncture may support stress reduction and improve blood flow to reproductive organs as part of comprehensive fertility care.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Antimullerian Hormone Concentration C4476970?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(1):1-15.

guideline2020View source →
2

La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers. Fertil Steril. 2014;101(4):1056-1064.

review2014View source →
3

Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217(2):129-140.

meta_analysis2017View source →
4

Devoto L, Kohen P, Strauss JF 3rd. The regulation of human ovarian follicular development: evidence from 3-dimensional imaging and anti-Müllerian hormone. Semin Reprod Med. 2019;37(1):12-19.

consensus2019View source →
5

Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12(6):685-718.

review2006View source →
6

American College of Obstetricians and Gynecologists. Female age-related fertility decline. Committee Opinion No. 589. Obstet Gynecol. 2014;123(3):719-721.

position_statement2014View source →
7

Hazout A, Bouchard DJ, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimüllerian hormone and Mullerian inhibiting substance appear to be potential markers of reproductive ageing in women. Fertil Steril. 2006;86(3):722-729.

clinical_trial2006View source →
8

European Society of Human Reproduction and Embryology (ESHRE). ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-937.

guideline2016View source →
9

Kruszyński W, Wołczyński S. Anti-Müllerian hormone (AMH): structure, functions and role in polycystic ovary syndrome. Endokrynol Pol. 2018;69(3):336-342.

review2018View source →
10

Strauss JF, Barbieri RL, editors. Yen & Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. 8th ed. Elsevier; 2018.

textbook2018View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Antimullerian Hormone Concentration C4476970. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy